NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

Couldn't the EAP kinda sorta serve as a confirmatory trial for the mesenchymal group? It will have plenty of pseudos in it. Anyhow, if it can't, then perhaps they filed for a BLA for mesenchymal.

And remember, while the number of randomized patients may only be 32... they've got all the pseudos in the open EAP trial that they can also submit the data on. AND... if there were pseudos in the Indeterminate Arm... as all of you who aren't invested insisted there were... then they could have done a subtype analysis on those patients, and if they were mesenchymal... submitted their data too.

And guess what? They don't need to PR any of that.... so long as they keep it nice and secret. In fact, it's best for them not to... if that's what they did. If they are refused... no worries. If they get it, then it's really no worries. :)

Because then they can PR it. :)